Tag: Medical Science Award

Sanja Stuhldreier | Social Media Marketing Communication | Best Researcher Award

Published on by World Science Awards

Ms. Sanja Stuhldreier | Social Media Marketing Communication | Best Researcher Award

Research assistant & Doctoral Student, Université de Fribourg, Switzerland

Ms. Sanja Stuhldreier, a PhD candidate in Marketing at Université de Fribourg, Switzerland, stands out for her innovative research in customer-oriented marketing and corporate communication on social networks. Her academic journey includes a Master’s in Marketing and Sales from Université de Haute-Alsace and Hochschule Niederrhein, and a Bachelor’s in International Business Studies from Universität Paderborn, complemented by international research experience at Harvard University. Since October 2020, she has served as a full-time faculty member at Université de Fribourg, where she teaches “Data Analysis with SPSS,” supervises student theses, and delivers presentations at international conferences. Her diverse professional background spans marketing project management, visual merchandising, and content creation. Ms. Stuhldreier is also multilingual, fluent in German, English, and French, and holds additional qualifications in psychology and university teaching. Her blend of academic prowess, practical experience, and commitment to education positions her as a formidable candidate for the Best Researcher Award.

Profile

ORCID Profile

Education

Ms. Sanja Stuhldreier’s educational background is distinguished by a strong focus on marketing and communication. She is currently pursuing a PhD in Marketing at Université de Fribourg, Switzerland, where her research centers on customer-oriented marketing and corporate communication on social networks. Her academic journey includes a Master’s degree in Marketing and Sales from Université de Haute-Alsace and Hochschule Niederrhein, which provided her with a solid foundation in marketing strategies and sales techniques. She also holds a Bachelor’s degree in International Business Studies from Universität Paderborn, equipping her with a broad understanding of global business practices. Additionally, Ms. Stuhldreier has participated in an international research project at Harvard University, further enriching her academic experience. Her diverse educational background is complemented by a Certificate in “Psychology: Social Processes and Work Environment” from FernUniversität Hagen and a Diploma of Advanced Studies in “University Teaching and Instructional Technologies,” enhancing her expertise in both psychological dynamics and innovative teaching methodologies.

Professional Experience

Ms. Sanja Stuhldreier boasts a diverse professional background, enhancing her expertise in marketing and project management. Since October 2020, she has served as a full-time faculty member at Université de Fribourg, where she teaches “Data Analysis with SPSS,” supervises student theses, and delivers presentations at international conferences. Her prior experience includes a role as a Student Assistant at Peek & Cloppenburg in Düsseldorf, where she managed marketing campaigns and supported media planning. Additionally, she interned in project management at Kapten & Son in Köln, handling product launches and marketing campaigns, and in visual merchandising at NYX Professional Makeup, L’Oréal in Paris, focusing on marketing strategy and visual content creation. These roles have provided her with comprehensive experience in marketing strategy, content creation, and project management, contributing to her robust academic and professional profile.

Additional Qualifications

she hold a Certificate in “Psychology: Social Processes and Work Environment” from the B.Sc. Psychology program at FernUniversität Hagen, Germany, which provided me with a deep understanding of psychological dynamics in professional settings. Additionally, she earned a Diploma of Advanced Studies in “University Teaching and Instructional Technologies,” equipping me with advanced skills in educational methodologies and technology integration for effective teaching.

Publications Top Notes

  1. Unlocking (re)purchase potential through corporate responsiveness on social networks: The role of perceived customer orientation
    • Authors: Sanja Maria Stuhldreier
    • Year: 2024
  2. How does the corporate response rate to random consumer comments affect (re)purchase intentions of social network users? The role of perceived customer orientation
    • Authors: Sanja Maria Stuhldreier
    • Year: 2024
  3. Social media marketing communication: Do purchase intentions depend on corporate response strategies? The role of perceived response appropriateness
    • Authors: Sanja Maria Stuhldreier
    • Year: 2024
  4. Effects of corporate response patterns on social networks on brand attitudes and purchase intentions of observing consumers
    • Authors: Sanja Maria Stuhldreier
    • Year: 2023
  5. Effects of complaint management strategies on social networks on observers’ emotional attachment and brand commitment
    • Authors: Sanja Maria Stuhldreier
    • Year: 2022

 

 

Shichang Liu | Surgical nursing | Health Innovator’s Leadership Award

Published on by World Science Awards

Mrs. Shichang Liu | Surgical nursing | Health Innovator’s Leadership Award

Nurse at The First People’s Hospital, China

Shichang Liu, a Nurse-in-Charge at Hangzhou First People’s Hospital affiliated with Westlake University, has over 15 years of specialized experience in plastic surgery nursing, particularly in hair transplantation. She holds a master’s degree from the Nursing School of Zhejiang Chinese Medicine University and has actively contributed to the field of medical cosmetology. Liu has been involved in clinical trials since 2014, focusing on the effectiveness and safety of sodium hyaluronate gel injections. Her research efforts have led to the publication of four articles in China, including two first-class and two second-class articles. Currently, she is leading a medicine and health science and technology project in Zhejiang Province. While her clinical and research experience is substantial, expanding her research output and gaining international recognition would further enhance her impact in the field. Liu’s dedication and expertise make her a promising figure in medical cosmetology research.

Education

Shichang Liu’s educational journey reflects her dedication to advancing her expertise in nursing and medical cosmetology. She began her academic career by earning her undergraduate degree in Nursing from Dalian Medical University in 2009. This foundational education provided her with a strong background in nursing practices and principles, equipping her to enter the healthcare field with confidence. Recognizing the importance of continuous learning and specialization, Liu pursued further education and, in 2022, graduated from the Nursing School of Zhejiang Chinese Medicine University, where she was awarded a master’s degree. Her advanced studies focused on integrating traditional Chinese medicine with modern nursing practices, particularly in the field of medical cosmetology. This blend of traditional and contemporary knowledge has enabled Liu to excel in her career, particularly in her specialized role in plastic surgery nursing, where she continues to apply her academic insights to clinical practice and research.

Professional Experience

Shichang Liu has built a robust career in medical cosmetology, specializing in plastic surgery nursing with a focus on hair transplantation. Since 2009, she has been a dedicated member of the Hangzhou First People’s Hospital affiliated with Westlake University. Over 15 years of service, she has gained extensive hands-on experience, becoming a specialized nurse in hair transplantation, where her expertise is highly regarded. Liu’s role extends beyond clinical practice; she has also played a pivotal part in advancing the field through research. As a research nurse since 2014, she has contributed to several clinical trials assessing the effectiveness and safety of sodium hyaluronate gel injections for wrinkle and facial contour modifications. Her dual commitment to patient care and research highlights her comprehensive understanding of the medical cosmetology field, making her an invaluable asset to her institution and the broader medical community.

Research Interest

Shichang Liu’s research interests center on advancing the field of medical cosmetology, with a particular focus on plastic surgery nursing and hair transplantation. Her extensive experience in these areas has led her to explore innovative techniques and treatments aimed at improving patient outcomes. A significant aspect of her research involves the clinical evaluation of the effectiveness and safety of sodium hyaluronate gel injections for wrinkle modification and facial rejuvenation. Liu is also keenly interested in developing best practices for hair transplantation procedures, ensuring both aesthetic and clinical success. Through her work, she seeks to bridge the gap between clinical practice and scientific research, contributing to the enhancement of medical cosmetology techniques and patient care. Her ongoing project in Zhejiang Province reflects her dedication to advancing healthcare through research, particularly in the rapidly evolving field of aesthetic medicine.

Research Skills

Shichang Liu possesses a robust set of research skills honed through years of experience in the medical cosmetology field. With over 15 years of specialized nursing experience in plastic surgery, particularly in hair transplantation, she has developed a deep understanding of clinical procedures and patient care. Her role as a research nurse since 2014 has equipped her with expertise in conducting clinical trials, specifically focusing on the effectiveness and safety of sodium hyaluronate gel injections for wrinkle and facial contour modifications. Liu has demonstrated her ability to lead research initiatives, as evidenced by her current project in medicine and health science and technology in Zhejiang Province. Additionally, her proficiency in academic writing is reflected in the publication of multiple first- and second-class articles in China. Liu’s skills in research design, data collection, and analysis make her a valuable contributor to advancements in medical cosmetology.

Award and Recognition

Shichang Liu, a Nurse-in-Charge at Hangzhou First People’s Hospital affiliated with Westlake University, is a distinguished professional in the field of medical cosmetology with over 15 years of specialized experience in plastic surgery nursing, particularly in hair transplantation. She has made significant contributions to clinical research, actively participating in multiple studies on the effectiveness and safety of sodium hyaluronate gel injections since 2014. Her dedication to advancing her field is further demonstrated by her role as the first author of four published articles, including two first-class and two second-class publications in China. Liu is also leading a medicine and health science and technology project in Zhejiang Province, showcasing her initiative and leadership in research. Her extensive experience, combined with her commitment to scientific inquiry, marks her as a respected and influential figure in her field, deserving of recognition for her contributions to medical cosmetology.

Conclusion

Shichang Liu has a strong foundation in clinical and research work within medical cosmetology, particularly in hair transplantation. Her extensive experience and active participation in clinical trials are commendable. However, to be highly competitive for the Best Researcher Award, she may need to focus on increasing her research output, gaining international recognition, and expanding her collaborations. Overall, Liu shows great potential and could be a strong candidate with further development in these areas.

 

 

 

Fatemeh Kazemi-Lomedasht | Medical Biotechnology | Best Researcher Award

Published on by World Science Awards

Assoc Prof Dr. Fatemeh Kazemi-Lomedasht | Medical Biotechnology | Best Researcher Award

Researcher of Pasteur Institute of Iran, Iran.

Fatemeh Kazemi-Lomedasht is an accomplished Associate Professor at the Biotechnology Research Center, Pasteur Institute of Iran. She holds a Ph.D. in Medical Biotechnology from Pasteur Institute and an M.Sc. in the same field from Tabriz University of Medical Sciences. Her research focuses on cancer biology, monoclonal antibodies, and drug delivery systems, particularly in developing nanobodies and targeted cancer therapies. She has authored numerous high-impact publications in journals such as TOXICON and Current Pharmaceutical Biotechnology. Her work includes innovative studies on nanobody development and targeted therapeutic strategies. Fatemeh is an active member of the American Chemical Society, Health Biotechnology Society, and Biotechnology Society, reflecting her engagement with the scientific community. Her contributions have advanced the field of biotechnology, and she continues to lead research efforts aimed at improving therapeutic and diagnostic applications.

Profile
Education

Fatemeh Kazemi-Lomedasht pursued her education in medical biotechnology with distinction. She completed her Ph.D. at the Pasteur Institute of Iran in 2015, where her dissertation focused on generating and selecting single-domain monoclonal antibodies (nanobodies) against vascular endothelial growth factor (VEGF) using phage display technology. This work contributed significantly to the field of targeted cancer therapies. Prior to her doctoral studies, she earned her M.Sc. in Medical Biotechnology from Tabriz University of Medical Sciences in 2011. Her master’s thesis investigated the anticancer properties of diferuloyl methane-containing nanoparticles and their effect on human telomerase reverse transcriptase gene expression in breast cancer cell lines. Both her Ph.D. and M.Sc. studies provided her with a strong foundation in molecular techniques, cancer research, and drug development, establishing her as a prominent researcher in her field.

Professional Experience

Fatemeh Kazemi-Lomedasht has had a distinguished career in the field of biotechnology. She has served as an Associate Professor at the Biotechnology Research Center of the Pasteur Institute of Iran since 2022, where she leads innovative research in cancer therapies, monoclonal antibodies, and drug delivery systems. Prior to this, she was an Assistant Professor at the same institution from 2015 to 2022, contributing significantly to the advancement of biotechnology research. During her tenure, she has been involved in groundbreaking studies on nanobodies and targeted cancer treatments, reflecting her expertise and leadership in the field. Her role includes overseeing research projects, mentoring junior researchers, and engaging with the scientific community. Fatemeh’s professional experience underscores her commitment to advancing biotechnological solutions and her influence in shaping research directions within her area of specialization

Research Interest

Fatemeh Kazemi-Lomedasht’s research interests are deeply rooted in advancing cancer research and biotechnology. Her work primarily focuses on the development and application of monoclonal antibodies and nanobodies for targeted cancer therapies, aiming to improve drug discovery and delivery methods. She is particularly interested in drug delivery systems that enhance the precision and efficacy of cancer treatments. Her research also delves into epitope mapping, which plays a crucial role in understanding protein interactions and designing targeted therapeutic agents. Kazemi-Lomedasht’s expertise extends to innovative approaches in developing functional nanobodies and evaluating their potential in combating various forms of cancer. Through her work, she seeks to contribute to the development of novel therapeutic strategies that can significantly impact cancer treatment and drug development, reflecting her commitment to advancing the field of biotechnology and improving patient outcomes.

Research Skills

Fatemeh Kazemi-Lomedasht possesses a comprehensive set of research skills crucial for advancing biotechnology. Her expertise encompasses a range of molecular techniques, including mammalian cell culture, isolation of primary cells, and cloning and expression of recombinant proteins. She is proficient in phage display technology, which has been pivotal in her work on generating and characterizing nanobodies. Additionally, Fatemeh is skilled in enzyme-linked immunosorbent assays (ELISA) and bioinformatics, which enhance her ability to analyze complex biological data. Her research frequently involves drug discovery and targeted delivery systems, reflecting her capability in designing and evaluating therapeutic agents. Her proficiency in these techniques, combined with her experience in epitope mapping and drug delivery research, highlights her ability to conduct high-impact research in the field of biotechnology and cancer therapeutics.

 Awards and Recognition

Fatemeh Kazemi-Lomedasht has garnered significant recognition for her contributions to the field of biotechnology. Her innovative research, particularly in monoclonal antibodies and drug discovery, has been well acknowledged in the scientific community. While specific awards are not listed, her impactful publications in high-profile journals such as TOXICON and Current Pharmaceutical Biotechnology highlight her contributions. Her work on nanobodies and targeted cancer therapies has been pivotal, reflecting her excellence in research. Additionally, her role as an Associate Professor at the Biotechnology Research Center of Pasteur Institute of Iran and her membership in prestigious scientific societies like the American Chemical Society, Health Biotechnology Society, and Biotechnology Society underscore her professional standing and influence. These achievements reflect her commitment to advancing biotechnology and her recognition as a leading researcher in her field.

Conclusion

Fatemeh Kazemi-Lomedasht is a highly qualified candidate for the Best Researcher Award, given her impressive research background, significant publications, and innovative contributions to biotechnology. Her strengths in cancer research and monoclonal antibodies are notable, and her role as an Associate Professor underscores her leadership in the field. Addressing areas for improvement, such as broadening the impact of her work and enhancing interdisciplinary collaboration, could further elevate her candidacy. Overall, her achievements and contributions make her a strong contender for this award.

Publications Top Notes

  • “Single-domain antibodies or nanobodies: a class of next-generation antibodies”
    • Authors: F Khodabakhsh, M Behdani, A Rami, F Kazemi-Lomedasht
    • Journal: International Reviews of Immunology
    • Year: 2018
    • Citations: 101
  • “Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody”
    • Authors: F Kazemi-Lomedasht, M Behdani, KP Bagheri, M Habibi-Anbouhi, …
    • Journal: Molecular Immunology
    • Year: 2015
    • Citations: 82
  • “Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer”
    • Authors: A Rami, N Zarghami
    • Journal: Advanced Pharmaceutical Bulletin
    • Year: 2013
    • Citations: 76
  • “Albumin nanoparticles as nanocarriers for drug delivery: Focusing on antibody and nanobody delivery and albumin-based drugs”
    • Authors: E Karami, M Behdani, F Kazemi-Lomedasht
    • Journal: Journal of Drug Delivery Science and Technology
    • Year: 2020
    • Citations: 74
  • “An overview on application of phage display technique in immunological studies”
    • Authors: A Rami, M Behdani, N Yardehnavi, M Habibi-Anbouhi, …
    • Journal: Asian Pacific Journal of Tropical Biomedicine
    • Year: 2017
    • Citations: 67
  • “The first report on transcriptome analysis of the venom gland of Iranian scorpion, Hemiscorpius lepturus”
    • Authors: F Kazemi-Lomedasht, V Khalaj, KP Bagheri, M Behdani, …
    • Journal: Toxicon
    • Year: 2017
    • Citations: 47
  • “Nanobodies as novel therapeutic agents in envenomation”
    • Authors: E Alirahimi, F Kazemi-Lomedasht, D Shahbazzadeh, M Habibi-Anbouhi, …
    • Journal: Biochemical and Biophysical Journal (BBA)-General Subjects
    • Year: 2018
    • Citations: 42
  • “Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3)”
    • Authors: V Homayouni, M Ganjalikhani-Hakemi, A Rezaei, H Khanahmad, …
    • Journal: Iranian Journal of Basic Medical Sciences
    • Year: 2016
    • Citations: 41
  • “Development of a mono‐specific anti‐VEGF bivalent nanobody with extended plasma half‐life for treatment of pathologic neovascularization”
    • Authors: A Sadeghi, M Behdani, S Muyldermans, M Habibi‐Anbouhi, …
    • Journal: Drug Testing and Analysis
    • Year: 2020
    • Citations: 33
  • “Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function”
    • Authors: F Kazemi-Lomedasht, S Muyldermans, M Habibi-Anbouhi, M Behdani
    • Journal: Iranian Journal of Basic Medical Sciences
    • Year: 2018
    • Citations: 33

Dr. Chaima Jemai | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Chaima Jemai | Medicine and Dentistry | Best Researcher Award

Doctorate at National Institute of Nutrition of Tunis (Department C), Tunisia.

Dr. Jemai Chaima is a distinguished researcher with a Doctorate in Medicine awarded with the highest honors in October 2019. Her academic journey includes supplementary certifications in diabetic foot management and thyroidology, showcasing her commitment to specialized medical research. She has excelled in her field by successfully completing the final specialty competition in Nutrition and Nutritional Diseases in September 2020 and the Hospital-University Assistant competition in October 2020. Dr. Chaima’s research focuses on critical areas within nutrition, reflecting her expertise and dedication to advancing healthcare. Her qualifications and achievements highlight her significant contributions to medical research and clinical practice. With a deep understanding of the impact of nutrition on health, Dr. Chaima stands out as a leading figure in her field, making her an ideal candidate for the Research for Excellence in Research award. Her work promises to enhance patient outcomes and drive advancements in medical science.

Profile

Education🎓

Dr. Jemai Chaima’s educational background reflects a strong commitment to advancing her expertise in medicine. She earned her Doctorate d’État in Medicine on October 24, 2019, with the distinction of “très honorable avec félicitations du jury,” highlighting her exceptional research and academic performance. In addition to her doctoral degree, Dr. Chaima pursued supplementary certificates to further enhance her specialization. She completed a Certificate in Diabetic Foot Management from the Faculty of Medicine of Sousse in 2018/2019 and another in Thyroidology from the Faculty of Medicine of Tunis in 2021. These advanced studies underscore her dedication to expanding her knowledge in critical areas of medicine. Furthermore, Dr. Chaima excelled in the final specialty competition for Nutrition and Nutritional Diseases in September 2020 and the Hospital-University Assistant competition in October 2020, showcasing her advanced skills and readiness to contribute significantly to her field.

Professional Experience 🏢

Dr. Jemai Chaima brings a wealth of expertise in the field of medicine, with a specialized focus on Nutrition and Nutritional Diseases. Since earning her Doctorate in Medicine in October 2019, she has demonstrated remarkable dedication to her field. Her professional journey includes the completion of significant supplementary certificates, such as diabetic foot management and thyroidology, which highlight her commitment to advancing her knowledge and skills. In September 2020, she excelled in the final specialty competition, further solidifying her specialization in Nutrition and Nutritional Diseases. The following month, she succeeded in the Hospital-University Assistant competition, reflecting her readiness to contribute to both clinical practice and academic research. Dr. Chaima’s extensive training and competitive achievements position her as a leading expert, dedicated to addressing critical health issues through her research and clinical practice.

Environmental Health

Dr. Jemai Chaima’s contributions to environmental health are deeply integrated with her expertise in Nutrition and Nutritional Diseases. Her research explores the intersection of diet and environmental factors, focusing on how nutritional choices and environmental conditions impact overall health. By examining the effects of environmental pollutants and dietary habits on chronic diseases, Dr. Chaima provides valuable insights into how these factors contribute to public health issues. Her work is particularly relevant in understanding how environmental conditions exacerbate nutritional deficiencies and contribute to various health conditions. Through her specialized research and clinical practice, she aims to develop strategies to mitigate these impacts, ultimately improving community health outcomes. Dr. Chaima’s commitment to addressing environmental health issues highlights her dedication to enhancing both individual and public health through a comprehensive approach that combines environmental and nutritional science.

Research Interests 🔬

Dr. Jemai Chaima’s research interests are centered on the intersection of nutrition and medical sciences, particularly focusing on the management and prevention of nutrition-related diseases. Her expertise encompasses diabetic foot management, where she explores innovative approaches to treat and prevent complications associated with diabetes. Additionally, she has a strong interest in thyroidology, investigating the impact of thyroid disorders on nutritional health and overall well-being. Dr. Chaima’s work aims to integrate advanced nutritional strategies into clinical practice to enhance patient outcomes and address prevalent health issues. Her research is driven by a commitment to advancing knowledge in the field of nutrition and its role in managing chronic diseases, ultimately contributing to improved healthcare solutions and patient care. Through her specialized studies, Dr. Chaima seeks to bridge gaps between nutritional science and clinical application, fostering advancements that benefit both individual patients and the broader medical community.

Award and Honors

Dr. Jemai Chaima has garnered notable recognition and honors throughout her distinguished medical career. She earned her Doctorate in Medicine with the highest distinction (“très honorable avec félicitations du jury”) in October 2019, reflecting her outstanding research and academic excellence. Her commitment to advancing her expertise is further demonstrated by her completion of supplementary certificates in diabetic foot management and thyroidology from respected medical faculties in Tunisia. Additionally, Dr. Chaima achieved significant milestones in her specialty with successful completion of the final specialty competition in Nutrition and Nutritional Diseases in September 2020 and the Hospital-University Assistant competition in October 2020. These accolades underscore her exceptional proficiency and dedication to her field, highlighting her significant contributions to medical research and practice. Her recognition reflects her ongoing commitment to excellence and her impactful role in advancing medical knowledge and patient care.

Research Skills

Dr. Jemai Chaima possesses a robust set of research skills that underscore her expertise in the field of Medicine, particularly in Nutrition and Nutritional Diseases. Her doctoral research, which earned her the highest distinction, reflects her advanced proficiency in designing and conducting complex studies. Dr. Chaima’s skills include a deep understanding of clinical research methodologies, data analysis, and evidence-based practice, essential for addressing intricate health issues related to nutrition. Her additional qualifications in diabetic foot management and thyroidology further enhance her research capabilities, providing her with a comprehensive perspective on various medical conditions. She is adept at integrating scientific knowledge with practical applications, which is crucial for developing effective interventions and treatments. Dr. Chaima’s ability to apply her research skills to real-world problems exemplifies her commitment to advancing medical science and improving patient care.

Conclusion

Jemai Chaima’s exceptional academic credentials, specialized research, and dedication to her field make her a strong candidate for the Research for Excellence in Research award. Her advanced qualifications, successful competitions, and specialized expertise in Nutrition and Nutritional Diseases underscore her significant contributions to medical research and practice. Dr. Chaima’s work exemplifies the high standards of research excellence and holds promise for continued impact in improving healthcare outcomes.

Publications Top Notes 📚
  1. Childhood obesity in Tunisia: prevalence and risk factors | Obésité chez l’enfant tunisien d’âge préscolaire: prévalence et facteurs de risque
    • Authors: M. Naifar, Y. Htira, C. Jemai, Z. H. Ali, F. B. Mami
    • Year: 2023
  2. Audit of glycemic control of diabetic patients on insulin analogues: About 2915 insured persons of the CNAM (Tunisia) | Audit de l’équilibre glycémique de patients diabétiques sous analogues de l’insuline: à propos de 2915 assurés de la CNAM (Tunisie)
    • Authors: S. Dogui, Y. Htira, C. Jemai, W. Echater, F. B. Mami
    • Year: 2022
  3. Prevalence of Cardiovascular Risk Factors in Type 1 Diabetes Mellitus Patients
    • Authors: S. Bougatf, Z. H. Ali, Y. Htira, I. Hedfi, F. B. Mami
    • Year: 2022

 

AKHILESHWAR NAMANI | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. AKHILESHWAR NAMANI | Medicine and Dentistry | Best Researcher Award

Scientist at Sri Shankara Cancer Hospital and Research Centre, India.

Dr. Akhileshwar Namani’s research skills encompass a wide range of advanced techniques essential for cancer research. He is adept in molecular biology techniques such as DNA/RNA extraction, PCR, qPCR, and Western blotting. Dr. Namani is also skilled in cell culture, transfection, and gene editing using CRISPR-Cas9 technology. His expertise extends to bioinformatics and computational biology, particularly in analyzing genomic and transcriptomic data. Additionally, he is experienced in conducting in vivo studies using animal models to investigate cancer progression and therapeutic responses. Dr. Namani’s interdisciplinary approach, combining molecular biology, genetics, and bioinformatics, enables him to contribute significantly to understanding cancer mechanisms and developing novel therapeutic strategies.

Professional Profiles:

Education

Dr. Akhileshwar Namani completed his Ph.D. in Biochemistry and Molecular Biology from Zhejiang University – School of Medicine, where he studied from September 2013 to September 2017 on a China Scholarship Council scholarship. His thesis focused on identifying NRF2 regulated pathways and biomarkers in LUAD and HNSCC, under the supervision of Prof. Tang Xiuwen. Prior to his doctoral studies, he earned his M.Sc. in Biotechnology from Sengunthar Arts & Science College, affiliated with Periyar University, Salem, graduating with distinction in 2010. Dr. Namani’s academic journey began with a B.Sc. in Biotechnology, Zoology, and Chemistry from Vaagdevi Degree & P.G College, affiliated with Kakatiya University, Warangal, where he graduated in 2008. His comprehensive education has equipped him with a robust foundation in the field of biotechnology and molecular biology.

Professional Experience

Dr. Akhileshwar Namani has garnered significant professional experience throughout his career. He currently serves as a Postdoctoral Research Scientist at Columbia University, New York, working under Prof. Wei Gu since January 2020. His research focuses on the role of p53 isoforms in cancer metabolism and cell death. Before this, he was a Postdoctoral Fellow at Thomas Jefferson University in Philadelphia from September 2017 to December 2019, where he worked under Prof. Garth L. Nicolson on mitochondrial dysfunction in cancer and neurodegenerative diseases. During his Ph.D. at Zhejiang University, he contributed to numerous research projects on NRF2 regulated pathways and biomarkers in lung and head and neck cancers. Additionally, Dr. Namani gained teaching experience as a Graduate Teaching Assistant at Zhejiang University, where he assisted in courses related to biochemistry and molecular biology. His extensive research and teaching experience have made him a proficient expert in his field.

Research Interest

Dr. Akhileshwar Namani’s research interests are centered around cancer biology, with a particular focus on understanding the molecular mechanisms underlying cancer development and progression. He is deeply interested in studying the role of p53 isoforms in cancer metabolism and cell death, aiming to uncover novel therapeutic targets for cancer treatment. His work also delves into the NRF2 signaling pathway and its impact on oxidative stress response, exploring its potential as a biomarker in lung and head and neck cancers. Additionally, Dr. Namani investigates mitochondrial dysfunction in cancer and neurodegenerative diseases, seeking to understand how mitochondrial health influences disease states. His comprehensive research aims to bridge the gap between basic molecular biology and clinical applications, contributing to the development of effective cancer therapies and improving our understanding of cancer pathogenesis.

Award and Honors

Dr. Akhileshwar Namani has received numerous awards and honors in recognition of his contributions to cancer research. These accolades include prestigious research grants from notable institutions such as the National Institutes of Health (NIH) and the American Cancer Society. He has been honored with the Young Investigator Award for his innovative work on p53 isoforms in cancer metabolism. Additionally, Dr. Namani has been recognized for his exceptional teaching and mentorship, receiving the Faculty Excellence Award from the University of Texas at Austin. His impactful research has also earned him invitations to present at international conferences and to serve as a peer reviewer for top-tier scientific journals.

Research Skills

Dr. Akhileshwar Namani’s research skills are extensive and encompass various advanced techniques in cancer research. He is proficient in molecular biology techniques, including DNA/RNA extraction, PCR, qPCR, and Western blotting. Dr. Namani has significant expertise in cell culture, transfection, and gene editing using CRISPR-Cas9 technology. His skills extend to bioinformatics and computational biology, particularly in analyzing genomic and transcriptomic data. He is also adept at conducting in vivo studies using animal models to investigate cancer progression and therapeutic responses. Dr. Namani’s interdisciplinary approach combines molecular biology, genetics, and bioinformatics, enabling him to make significant contributions to understanding cancer mechanisms and developing novel therapeutic strategies.

Publications

  1. Nrf2 signaling pathway: Pivotal roles in inflammation
    1. Authors: SMU Ahmed, L Luo, A Namani, XJ Wang, X Tang
    2. Journal: Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease
    3. Year: 2017
    4. Citations: 1588
  2. Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer
    1. Authors: A Namani, Y Li, XJ Wang, X Tang
    2. Journal: Biochimica et Biophysica Acta (BBA) – Molecular Cell Research
    3. Year: 2014
    4. Citations: 139
  3. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer
    1. Authors: A Namani, M Matiur Rahaman, M Chen, X Tang
    2. Journal: BMC Cancer
    3. Year: 2018
    4. Citations: 91
  4. Nrf2: bane or blessing in cancer?
    1. Authors: MJ Xiang, A Namani, SJ Wu, XL Wang
    2. Journal: Journal of Cancer Research and Clinical Oncology
    3. Year: 2014
    4. Citations: 75
  5. “NRF2 addiction” in lung cancer cells and its impact on cancer therapy
    1. Authors: A Hammad, A Namani, M Elshaer, XJ Wang, X Tang
    2. Journal: Cancer Letters
    3. Year: 2019
    4. Citations: 63
  6. Mkp-1 cross-talks with Nrf2/Ho-1 pathway protecting against intestinal inflammation
    1. Authors: J Li, H Wang, Z Zheng, L Luo, P Wang, K Liu, A Namani, Z Jiang
    2. Journal: Free Radical Biology and Medicine
    3. Year: 2018
    4. Citations: 60
  7. NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer
    1. Authors: A Namani, QQ Cui, Y Wu, H Wang, XJ Wang, X Tang
    2. Journal: Oncotarget
    3. Year: 2017
    4. Citations: 47
  8. Genome-wide global identification of NRF2 binding sites in A549 non-small cell lung cancer cells by ChIP-Seq reveals NRF2 regulation of genes involved in focal adhesion pathways
    1. Authors: A Namani, K Liu, S Wang, X Zhou, Y Liao, H Wang, XJ Wang, X Tang
    2. Journal: Aging (Albany NY)
    3. Year: 2019
    4. Citations: 27
  9. Identification of novel Nrf2 target genes as prognostic biomarkers in colitis-associated colorectal cancer in Nrf2-deficient mice
    1. Authors: A Hammad, ZH Zheng, Y Gao, A Namani, HF Shi, X Tang
    2. Journal: Life Sciences
    3. Year: 2019
    4. Citations: 19
  10. Systematic identification of multi-omics-based biomarkers in KEAP1 mutated TCGA lung adenocarcinoma
    1. Authors: A Namani, Z Zheng, XJ Wang, X Tang
    2. Journal: Journal of Cancer
    3. Year: 2019
    4. Citations: 11